AAS

642 posts

AAS banner
AAS

AAS

@atheroaussie

The Australian Atherosclerosis Society (AAS) promotes, at a national level, the advancement of science, research and teaching in the field of atherosclerosis

Australia and New Zealand Katılım Ocak 2012
226 Takip Edilen487 Takipçiler
AAS
AAS@atheroaussie·
We are delighted to be partnering with the #IMMA conference. If you're considering joining the conference register now. The early bird price is live and plenty of oral presentation slots are on offer. For more information: bit.ly/4twsl2Z
AAS tweet media
English
0
0
1
49
AAS
AAS@atheroaussie·
Join us to her about some cutting-edge research at the joint virtual seminar, delivered by Dr Jonathan Noonan from the Baker Heart and Diabetes Institute
AAS tweet media
English
0
0
0
69
AAS
AAS@atheroaussie·
Looking forward to the next joint virtual seminar series tomorrow with Prof Gemma Figtree speaking. @AVBS_org @ANZMS2
AAS tweet media
English
0
0
5
100
AAS
AAS@atheroaussie·
The June AAS, AVBS, ANZMS joint virtual seminar will be held today- hope to see you there!
AAS tweet media
English
0
0
2
121
AAS
AAS@atheroaussie·
Great talk happening tomorrow at our joint seminar.
AAS tweet media
English
0
1
6
242
AAS
AAS@atheroaussie·
SAHMRI PhD student, Demeke Geremew had a very engaged audience at the poster session! #ISA2024
AAS tweet media
English
0
1
8
237
AAS
AAS@atheroaussie·
Panel discussion is lively!
AAS tweet media
English
0
0
2
104
AAS
AAS@atheroaussie·
In her second talk for the morning, @ChrisBursill is delivering a sponsored lunchtime lecture on Inflammation in Atherosclerosis #ISA2024
AAS tweet media
English
1
3
12
511
AAS
AAS@atheroaussie·
Former AAS President and long time member, @ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024
AAS tweet media
English
1
2
10
1.2K
AAS
AAS@atheroaussie·
Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024
AAS tweet media
English
0
1
5
282
AAS
AAS@atheroaussie·
Closing out the FH Summit is the interactive workshop focusing on the development of risk-reduction pathway for children led by @MitchellSarkies with insights from Shubha Srinivasan, Natalie Taylor & Andrew Martin.
AAS tweet mediaAAS tweet media
English
0
0
2
126